ArticleOncotarget2015

DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.

Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.